Fischer Medical Ventures Limited
Fischer Medical Ventures Limited (FISCHER): company summary
The company's business has grown significantly, with annual revenue rising 178.0% and net profit surging 3002.0% year-over-year.
Fischer Medical Ventures Limited (FISCHER) is a micro-cap Healthcare company valued at ₹1,926 crore operating in Medical Equipment & Supplies on the NSE and BSE.
- Recent price move
- Fischer Medical Ventures Limited last traded at ₹29.25, modestly down 0.41% on the day.
- Recent developments
- On 2026-09-22, the company announced a dividend of ₹0.05 per share, effective from that date. The latest quarter ended on 2026-06-30, showing revenue of ₹82 crore and net profit of ₹4 crore. The company's fiscal year ended on 2026-03-31, with annual revenue of ₹309 crore and net profit of ₹31 crore.
- Financial performance
- The company's business has grown significantly, with annual revenue rising 178.0% and net profit surging 3002.0% year-over-year. However, the latest quarter saw net profit fall 22.0% compared to the same quarter a year earlier, despite revenue increasing 249.5%.
- Valuation multiples
- The stock trades at 60.9 times earnings, a premium to the Healthcare median of 32.0, 4.98 times book value. It yields 0.1%.
- Things to watch
- The company's net profit fell 22.0% in the latest quarter compared to the same quarter a year earlier. The stock is 72.5% below its 52-week high, and the latest quarter's net profit was lower than the previous quarter's, which reported a net profit of ₹7 crore loss.
- Where it stands
- The company has experienced rapid growth in both revenue and net profit over the past year, with net profit margin improving by 9.2 percentage points. The latest quarter's net profit dropped 22.0% compared to the same quarter a year earlier, and the stock is 72.5% below its 52-week high.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.0) and risk (6.1), but held back by momentum (0.0).
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 354% a year
- Profit compounding 195% a year
- Loss-making in some of the last 5 years
- Valuation is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Medical Equipment & Supplies
Explore Fischer Medical Ventures Limited’s valuation
Free deep-dive tools · no sign-up
Fischer Medical Ventures Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Fischer Medical Ventures Limited with peers
Related tools & concepts
Value Fischer Medical Ventures Limited with the ratios and calculators DocStoX uses in its analysis.

